Participants 84 145 5
chemo-naïve patients with advanced non-small cell lung cance
Participants 290 338 3
 chemo-naïve non-small cell lung cancer patient
Participants 347 648 5
S Patients with chemo-naïve stage IIIB/IV non-small cell lung cancer were randomized into two treatment arms. Patients were given oral S-1 (60 mg/m/d, twice a day) from days 1 to 14 with gemcitabine (1000 mg/m/d) on days 1 and 8 (arm A) or on days 8 and 15 (arm B). This cycle was repeated every 21 d
Participants 658 707 5
TS A total of 80 patients were entered in this tr
